Get the Stockscreener App
1.86
9.41%
0.16
After Hours:
1.64
-0.22
-11.83%
Co Diagnostics Inc stock is traded at $1.86, with a volume of 248.07K.
It is up +9.41% in the last 24 hours and down -62.11% over the past month.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
See More
Previous Close:
$1.70
Open:
$1.72
24h Volume:
248.07K
Relative Volume:
0.24
Market Cap:
$3.90M
Revenue:
$507.90K
Net Income/Loss:
$-32.18M
P/E Ratio:
-0.0849
EPS:
-21.9125
Net Cash Flow:
$-31.81M
1W Performance:
-18.06%
1M Performance:
-62.11%
6M Performance:
-64.22%
1Y Performance:
-87.42%
1-Day Range:
$1.72
$1.9175
1-Week Range:
$1.66
$2.36
52-Week Range:
$1.66
$3.95
Co Diagnostics Inc Stock (CODX) Company Profile
Name
Co Diagnostics Inc
Sector
Industry
Phone
(801) 278-9769
Address
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
Compare CODX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
1.86 | 3.56M | 507.90K | -32.18M | -31.81M | -21.91 |
ABT
Abbott Laboratories
|
102.67 | 177.03B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.59 | 124.89B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.65 | 110.08B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.75 | 93.53B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
80.08 | 45.84B | 6.07B | 1.06B | 1.34B | 1.8063 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-12-22 | Downgrade | Sidoti | Buy → Neutral |
| Dec-29-21 | Initiated | Sidoti | Buy |
| Mar-29-21 | Downgrade | Maxim Group | Buy → Hold |
| May-20-20 | Upgrade | Maxim Group | Hold → Buy |
| May-18-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-09-20 | Reiterated | H.C. Wainwright | Buy |
| Mar-03-20 | Downgrade | Maxim Group | Buy → Hold |
View All
Co Diagnostics Inc Stock (CODX) Latest News
Co-Diagnostics Q4 2025 earnings preview - MSN
Co-Diagnostics Expands South Asia Footprint, Targeting $13B Diagnostics Opportunity - USA Today
Exclusive: Co-Diagnostics ships diagnostic tests to India ahead of TB study launch - MSN
Exclusive: Co-Diagnostics expands South Asia reach, targets $13 billion market opportunity - msn.com
FRA:C970 PB Ratio: 0.24 — 86% Below Median - GuruFocus
Co-Diagnostics Inc expected to post a loss of $3.60 a shareEarnings Preview - TradingView
Q2 2025 Co-Diagnostics Inc Earnings Call Transcript - gurufocus.com
EXCLUSIVE: Co-Diagnostics Ships Diagnostic Tests To India Ahead Of TB Study Launch - Sahm
Co-Diagnostics ships TB testing materials to India for studies By Investing.com - za.investing.com
Q3 2025 Co-Diagnostics Inc Earnings Call Transcript - gurufocus.com
CODX Technical Analysis | Trend, Signals & Chart Patterns | CO-DIAGNOSTICS INC (NASDAQ:CODX) - ChartMill
Co-Diagnostics ships TB testing materials to India for studies - Investing.com India
Co-Diagnostics Ships Diagnostic Materials to India for Initiation of Tuberculosis Clinical Studies Following Recently Issued Guidance from the World Health Organization - marketscreener.com
Recap Report: Should I set a stop loss on Co Diagnostics IncWeekly Trend Recap & Expert Approved Trade Ideas - baoquankhu1.vn
Co-Diagnostics expands commercial and distribution territory across South Asia - BioSpectrum Asia
Co-Diagnostics and CoSara expand distribution across South Asia - Yahoo Finance
EXCLUSIVE: Co-Diagnostics Expands South Asia Reach, Targets $13 Billion Market Opportunity - AOL.com
Co-Diagnostics (NASDAQ: CODX) Expands CoSara Distribution Territory Across South Asia - The Globe and Mail
Dow Falls Over 100 Points; FedEx Posts Upbeat Earnings - Sahm
Chart Watch: What analysts say about Co Diagnostics Inc stockTrend Reversal & Low Drawdown Momentum Ideas - baoquankhu1.vn
Nasdaq Down Over 1%; XPeng Shares Fall After Q4 Results - Sahm
Co-Diagnostics expands South Asia distribution territory By Investing.com - Investing.com Australia
Co-Diagnostics Inc. Sees Volatile Movements Amid Market Developments - timothysykes.com
## Recent Developments: Key Market Insights - StocksToTrade
CODX Stock Observes Notable Trends Following Strategic Developments - timothysykes.com
Co-Diagnostics Shares Slip Amidst Market Headwinds and Financial Challenges - StocksToTrade
Co-Diagnostics Inc.’s Stock Surges Amid Strategic Moves and Partnerships - timothysykes.com
Co-Diagnostics (CODX) Expands CoSara Distribution Territory Across South Asia - NewMediaWire
Chipmakers Recap: What analysts say about Co Diagnostics Inc stock2026 Sector Moves & Capital Efficiency Focused Strategies - baoquankhu1.vn
CODX Stock Reverses Pre-Market Gains Driven By South Asia Expansion Deal – Retail Highlights ‘Dead Cat Rally’ - Stocktwits
Co-Diagnostics (CODX) Stock Surges 9% Following Major South Asian Market Expansion - Blockonomi
Co-Diagnostics (CODX) Stock Jumps 9% on South Asia Expansion Deal - CoinCentral
Co-Diagnostics Eyes Global Expansion with New Japanese Patent - StocksToTrade
Co-Diagnostics jumps as it expands South Asia distribution footprint - quiverquant.com
Co-Diagnostics Latest Moves Juice International Hopes - timothysykes.com
Co-Diagnostics Signs Agreement to Significantly Expand Commercia - GuruFocus
Purple Biotech Is Building What Could Be the Next Generation of Cancer Immunotherapy (NASDAQ: PPBT) - Benzinga
Why Did CODX Stock Surge 45% In Pre-Market Today? - Stocktwits
Co-Diagnostics, Inc. (CODX) has signed a key agreement to extensively expand its commercial operations and product distribution network across South Asia. - Bitget
Co-Diagnostics expands South Asia distribution territory - Investing.com
Co-Diagnostics Signs Agreement to Significantly Expand Commercial and Distribution Territory Across South Asia - Financial Times
Co-Diagnostics (FRA:C970) Cyclically Adjusted Price-to-FCF : (As of Mar. 19, 2026) - GuruFocus
HC Wainwright & Co. Reiterates Co-Diagnostics (CODX) Neutral Recommendation - MSN
Co Diagnostics Inc Stock (CODX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):